Dysembryoplastic Neuroepithelial Tumour (DNET)

Dysembryoplastic neuroepithelial tumours (DNET or DNT) are a rare of central nervous system (CNS) tumour that generally develop within cortical grey matter, which are the outer most regions of the brain and spinal cord that contain a high concentration of nerve cells. DNETs are classified as glioneural tumours, as they contain both glial cells (supportive cells within the central nervous system) and nerve cells/neuronal cells (receive sensory input from internal and external stimuli, and relay information to the brain).

The brain is a complex organ that is responsible for controlling all functions of the body. It has five main portions: the cerebrum, cerebellum, brainstem, pituitary gland, and hypothalamus. The cerebrum is the biggest part of the brain, and consists of the frontal, parietal, temporal, and occipital lobes. This part of the brain is responsible for voluntary movement, intelligence, and memory. The cerebellum is a small part of the brain located at the back of the head, and regulates posture and balance. The brainstem is a small, stalk-like structure towards the bottom of the brain that connects the brain to the spinal cord.  It regulates many vital bodily processes, such as swallowing, breathing, and heart rate. The pituitary gland is a pea sized organ located behind the eyes, and is responsible for the production and secretion of hormones in the body. The hypothalamus is located deep within the brain, and has many important functions, such as producing and secreting different hormones, regulating temperature, and controlling appetite.

The spinal cord is a long, thin, tubular structure that extends down from the brainstem to the lower back. It is made of nerve tissue, and is surrounded by the bones of the spine (vertebrae). The spinal cord is responsible for transmitting nerve signals from the brain to the body, and vice versa. It has motor functions (such as voluntary movement), sensory functions (such as pressure, touch, temperature, and pain), and autonomous functions (such as regulating digestion, heart rate, and blood pressure).

DNETs are generally considered to be slow-growing and benign (non-cancerous) tumours. They most commonly develop in the grey matter of the cerebral cortex, however it can also develop in the basal ganglia (cluster of neurons beneath the cerebral cortex), brain stem, and cerebellum. DNETs that develop in the septum pellucidum (thin layer between the right and left hemispheres of the brain) are now classified separately, and are called myxoid glioneural tumours.

DNETs are slightly more common in males, and are generally diagnosed in people under the age of 20. However, anyone can develop this disease.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, as most DNETs are considered benign, these tumours are generally considered low-grade and are not staged.

Once your tumour has been diagnosed, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including location, age, stage of disease and overall health.

Treatment options for DNETs may include:

  • Surgery to remove as much of the tumour as possible.
  • Clinical trials.
  • Palliative care.

Unfortunately, this type of cancer does not often respond to chemotherapy and radiation therapy.

Risk factors

Because of how rare DNETs are, there has been limited research done into the risk factors of this disease.

Symptoms

The main symptom of DNETs are focal seizures, which are a malfunction of nerve cells that result in intense, uncontrolled, and sudden surge of electrical impulses across the brain. In many cases, a patients first seizure will occur before the age of ten, and will occur without any other physical or neurological symptoms.. Seizures that are the result of a DNET are often resistant to anti-seizure medication.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have a DNET, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Neurological examination.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
  • Blood tests.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.